Analysis
Sheridan Capital Partners has closed its fourth flagship fund, Fund IV, at its $1.1 billion hard cap, and separately closed a $245 million first dedicated healthcare IT fund, Pulse 2.0 reports. The firm says Fund IV was oversubscribed and fully allocated in under 60 days from the start of fundraising, drawing commitments from both new and existing institutional investors.
The Chicago-based firm invests exclusively in healthcare, with a thesis-driven approach that pairs industry expertise with operational resources across outsourced services, healthcare products and manufacturing, patient services and providers. Co-founders and partners Jonathan Lewis and Sean Dempsey lead the firm. Fund III's recent platform investments included Carolina Components Group, Tres Health and Currier Plastics.
Betting On Fragmented Healthcare IT
The new Healthcare IT Fund I targets a specific niche: lower middle-market healthcare technology companies in North America that Sheridan believes stand to benefit from digitization, rising efficiency demands and faster software adoption across the healthcare system. The fund has already made three platform investments through this strategy, Cadara, ICANotes and PTEverywhere, betting that fragmented healthcare IT markets can be consolidated the way Sheridan has previously consolidated healthcare services businesses.
Sheridan's healthcare-only focus puts it alongside other sector-specialist growth and buyout firms like Shore Capital Partners and Martis Capital, both of which run similar thesis-driven, platform-based strategies in healthcare services rather than generalist buyouts.
At $1.1 billion, Fund IV is nearly double Fund III's $575 million, a jump that comes amid a broader slowdown in buyout fundraising timelines across private equity. Evercore's Private Funds Group ran exclusive placement on Fund IV, Harris Williams placed the Healthcare IT Fund, and Kirkland & Ellis served as legal counsel on both, an advisory roster more typical of a much larger generalist firm.
The tradeoff of a sector-only strategy is concentration: Sheridan's returns now depend heavily on healthcare-specific dynamics like reimbursement policy and regulatory change, and a fundraise that closes in under 60 days can also mean a narrower LP base had the chance to participate before the fund filled.
Whether Cadara, ICANotes and PTEverywhere can actually consolidate the fragmented healthcare IT niche Sheridan is targeting will be the real test of this fund's thesis.